Log In
Print
BCIQ
Print
Print this Print this
 

lasmiditan (COL-144)

Also known as: formerly IY573144

  Manage Alerts
Collapse Summary General Information
Company CoLucid Pharmaceuticals Inc.
DescriptionSelective agonist of serotonin (5-HT1F) receptor
Molecular Target Serotonin (5-HT1F) receptor
Mechanism of ActionSerotonin (5-HT1F) receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationMigraine
Indication DetailsTreat acute migraine
Regulatory Designation

Partner

Ildong Pharmaceutical Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today